---

Call for proposals MCT8 Research 2019

---

The MCT8 Resaerch Foundation is focusing on funding programs devoted to the improvement of the health and welfare of patients. This objective can be achieved through studies aimed at understanding disease mechanisms, developing natural history studies including outcome measures and biomarkers, and conducting clinical trials.

---

Application submission deadline: September 2nd, 2019

---

Themes proposed in the 2019 call for proposals will focus on unmet needs in the field of MCT8 deficiency, i.e. Allan-Herndon-Dudley-Syndrom (AHDS).

---

Research Topics of Interest include:

---

1. Clinical trial / clinical trial readiness for AHDS including the development of longitudinal outcome measures, biomarker characterization, imaging modalities and pharmacodynamics / pharmacokinetic studies.
2. Preclinical studies specifically testing therapies (gene, cell, enzyme or pharmacologic therapies) for AHDS.
3. Developing animal or cell-based models (e.g. patient derived iPSC)
4. Study of mechanisms responsible for AHDS, in order to identify new therapeutic approaches.

Direct costs cannot exceed 200.000 EUR for a maximum funding period of two years.

Grant instructions and policies are available below.

For more information, contact the MCT8 Research Department at:
MCT8 Forschung e.V. – Ludwig-Richter-Str. 5 – 35396 Giessen, Germany.
E-mail: info@mct8-research.com

Grant Instructions and Policies